Bacterial meningitis and epilepsy

Epilepsia

Volumn 49, Issue SUPPL.6, 2008, Pages 8-12

  Murthy, Jagaralapudi Murali K ^a   Prabhakar, Sudesh ^b  

^a CARE HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bacterial meningitis; Risk factors; Unprovoked seizures epilepsy

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID DERIVATIVE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PLACEBO; POLYSACCHARIDE VACCINE;

ACUTE DISEASE; ANTIBIOTIC THERAPY; ATTRIBUTABLE RISK; BACTERIAL MENINGITIS; CENTRAL NERVOUS SYSTEM INFECTION; CHRONOLOGY; CLINICAL TRIAL; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; EARLY DIAGNOSIS; ENDEMIC DISEASE; EPIDEMIC; EPILEPSY; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION PREVENTION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; PERCEPTION DEAFNESS; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SEIZURE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SYMPTOMATOLOGY; VACCINATION;

COST OF ILLNESS; DEVELOPING COUNTRIES; EPILEPSY; HUMANS; INCIDENCE; MENINGITIS, BACTERIAL; PREVALENCE; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STREPTOCOCCAL INFECTIONS;

EID: 50249121996     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01750.x     Document Type: Review

References (40)

1. al-Rajeh S, Abomelha A, Awada A, Bademosi O, Ismail H 1990) Epilepsy and other convulsive disorders in Saudi Arabia: a prospective study of 1,000 consecutive cases. Acta Neurol Scand 82 : 341 345.
2. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT 1988) The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38 : 1407 1410.
3. Anonymous 1995) Control of epidemic meningococcal diseases. WHO practical guidelines. World Health Organization and Foundation. Marcel Mericux, Edition Foundation. Marcel Mericux, Lyon, France.
4. Auburtin M, Wolff M, Charpentier J, Varon E, Tulzo YL, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Richard J, Timsit J 2006) Detrimental role of delayed antibiotic administration and penicillin non-susceptible stains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 34 : 2758 2765.
5. Baraff LJ, Lee SI, Schriger DL 1999) Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 12 : 389 394.
6. Bedford H, de Louvois J, Halket S, Peckham C, Hurley R, Harvey D 2001) Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ 323 : 533 536.
7. Bergamini L, Bergamasco B, Benna P, Gilli M 1977) Acquired etiological factors in 1,785 epileptic subjects: clinical-anmnestic research. Epilepsia 18 : 437 444
8. Brundage JF, Ryan MA, Feighner BH, Erdtmann FJ 2002) Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998. Clin Infect Dis 35 : 1376 1381.
9. Chang CJ, Chang HW, Chang WN, Huang LT, Huang SC, Chang YC, Hung PL, Chang CS, Chuang YC, Huang CR, Tsai NW, Tsui HW, Wang KW, Lu CH 2004) Seizures complicating infantile and childhood bacterial meningitis. Pediatr Neurol 31 : 165 171.
10. Commission on tropical diseases of the International League Against Epilepsy 1994) Relationship between epilepsy and tropical diseases. Epilepsia 35 : 89 93.
11. Cowgill KD, Ndiritu M, Nyiro J, Slack MPE, Chiphatsi S, Ismail A, Kamau T, Mwangi I, English M, Newton CRJC, Feikin DR, Scott AG 2006) Effectiveness of Hemophilus influenzae type b vaccine introduction into routine childhood immunization in Kenya. JAMA 296 : 671 678.
12. Daza P, Banda R, Misoya K, Katsulukuta A, Gessner BD, Katsande R, Mhlanga BR, Mueller JE, Nelson CB, Phiri A, Molyneux EM, Molyneux ME 2006) The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. Vaccine 24 : 6232 6239.
13. de Graaf AS 1974) Epidemiological aspects of epilepsy in northern Norway. Epilepsia 15 : 291 299
14. Dery MA, Hasbun R 2007) Changing epidemiology of bacterial meningitis. Curr Infect Dis Rep 9 : 301 307.
15. Fitch M, van de Beek D 2007) Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis 7 : 191 200.
16. Greenwood B 2006) 100 years of epidemic meningitis in West Africa - has anything changed? Trop Med Int Health 11 : 773 780.
17. Hauser WA, Kurland LT 1975) The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 16 : 1 66.
18. Jornada Krebs VL, De Albuquerque Diniz EM, Costa Vaz FA, Marques Dias MJ, Takiguti C, Araújo Ramos JL 1996) Neonatal bacterial meningitis: prospective study of the long-term outcome of 55 children. Arq Neuropsiquiatr 54 : 75 81.
19. Kainer M, Mc Cauley T, Craig AS 2005) Prevention of early-onset group B streptococcal disease in newborn. Tenn Med 98 : 232 233.
20. Kim KS 2003) Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 4 : 376 385.
21. Klinger G, Chin CN, Beyene J, Perlman M 2000) Predicting the outcome of neonatal bacterial meningitis. Pediatrics 106 : 477 482.
22. Koedel U, Scheld WM, Pfister HW 2002) Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2 : 721 736.
23. Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, Tan T 2007) Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol 6 : 533 543.
24. Marks DA, Kim J, Spencer DD, Spencer SS 1992) Characteristics of intractable seizures following meningitis and encephalitis. Neurology 42 : 1513 1518.
25. Murthy JMK, Yangala R 1998) Etiological spectrum of localization-related epilepsies: a study from south India. J Neurol Sci 158 : 65 70.
26. Murthy JMK, Yangala R, Srinivas M 1998) The syndromic classification of the International League Against Epilepsy: a hospital-based study from south India. Epilepsia 39 : 48 54.
27. O'Brien TJ, Moses H, Cambier D, Cascino GD 2002) Age of meningitis or encephalitis is independently predictive of outcome from anterior temporal lobectomy. Neurology 58 : 104 109.
28. Peltola H 1997) Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J 16 : 780 787.
29. Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD 1990) Seizures and other neurologic sequelae of bacterial meningitis in children. N Eng J Med 323 : 1651 1657
30. Preux PM, Druet-Cabanac M 2005) Epidemiology and etiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4 : 21 31.
31. Rantakallio P, Leskinen M, von Wendt L 1986) Incidence and prognosis of central nervous system infections in a birth cohort of 12000 children. Scand J Infect Dis 18 : 287 294.
32. Rosman NP, Peterson DG, Kaye PM, Coulton T 1985) Seizures in bacterial meningitis: prevalence, patterns, pathogenesis, and prognosis. Pediatr Neurol 1 : 278 285.
33. Salih MA, Khaleefa OH, Bushara M, Taha ZB, Musa ZA, Kamil I, Hofvander Y, Olcen P 1991) Long term sequelae of childhood acute bacterial meningitis in a developing country: a study from the Sudan. Scand J Infect Dis 23 : 175 182.
34. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A 2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 51 : 1 22.
35. Sell SH, Merill RE, Doyne EO, Zimsky EP Jr. 1977) Long-term sequelae of Hemophilus influenzae meningitis. Pediatrics 49 : 206 211.
36. Stevens JP, Eames M, Kent A, Halket S, Holt D, Harvey D 2003) Long term outcome of neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 88 : F179 184.
37. Stoll BJ 1997) The global impact of neonatal infection. Clin Perinatol 24 : 1 21.
38. Tikhomirov E, Santamaria M, Esteves K 1997) Meningococcal disease: public health burden and control. World Health Stat Q 50 : 170 177.
39. van de Beek D, de Gana J, McIntyre P, Prasad K 2004) Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 4 : 139 143.
40. Wahdan MH, Sallam SA, Hassan MN, Abdel Gawad A, Rakha AS, Sippel JE, Hablas R, Sanborna WR, Kassem NM, Riad SM, Cvjetanovic B 1977) A second controlled field trial of a serogroup. A meningococcal polysaccharide vaccine in Alexandria. Bull World Health Organ 55 : 645 651.